Regorafenib in Metastatic Colorectal Cancer : a Cohort Study in the Real-life Setting

ABSTRACT: This is a largest cohort study aimed to estimate the overall survival of patients been treated with regorafenib for metastatic colorectal cancer (mCRC) within the frame of a french compassionate program.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2179782 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR